These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10685471)

  • 1. [Serum procalcitonin and respiratory tract infections].
    Zarka V; Valat C; Lemarié E; Boissinot E; Carré P; Besnard JC; Diot P
    Rev Pneumol Clin; 1999 Dec; 55(6):365-9. PubMed ID: 10685471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-operative kinetics of procalcitonin after lung transplantation.
    Desmard M; Benbara A; Boudinet S; Mal H; Dehoux M; Thabut G; Montravers P
    J Heart Lung Transplant; 2015 Feb; 34(2):189-94. PubMed ID: 25447581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic utility of procalcitonin in community-acquired respiratory tract infections--a literature review].
    Wróblewski T; Marcisz C; Kurzawska G
    Postepy Hig Med Dosw (Online); 2004; 58():495-505. PubMed ID: 15765011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of serum procalcitonin levels in pulmonary tuberculosis.
    Ugajin M; Miwa S; Shirai M; Ohba H; Eifuku T; Nakamura H; Suda T; Hayakawa H; Chida K
    Eur Respir J; 2011 Feb; 37(2):371-5. PubMed ID: 20530033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia.
    Schleicher GK; Herbert V; Brink A; Martin S; Maraj R; Galpin JS; Feldman C
    Eur Respir J; 2005 Apr; 25(4):688-92. PubMed ID: 15802344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
    Müller B; Harbarth S; Stolz D; Bingisser R; Mueller C; Leuppi J; Nusbaumer C; Tamm M; Christ-Crain M
    BMC Infect Dis; 2007 Mar; 7():10. PubMed ID: 17335562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of serum procalcitonin measurement in the diagnosis of respiratory infectious diseases].
    Kurata K; Kazuyori T; Shimizu K; Kubota M; Hamaguchi R; Wakaki M; Goto T; Onaka A; Kato R; Oyamada Y
    Nihon Kokyuki Gakkai Zasshi; 2010 Sep; 48(9):654-60. PubMed ID: 20954366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection.
    Dörge H; Schöndube FA; Dörge P; Seipelt R; Voss M; Messmer BJ
    Thorac Cardiovasc Surg; 2003 Dec; 51(6):322-6. PubMed ID: 14669128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.
    Lindstrom ST; Wong EK
    Intern Med J; 2014 Apr; 44(4):390-7. PubMed ID: 24528892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleural fluid and serum procalcitonin as diagnostic tools in tuberculous pleurisy.
    Cakir E; Deniz O; Ozcan O; Tozkoparan E; Yaman H; Akgul EO; Bilgi C; Bilgic H; Ekiz K; Erbil MK
    Clin Biochem; 2005 Mar; 38(3):234-8. PubMed ID: 15708544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis.
    Polzin A; Pletz M; Erbes R; Raffenberg M; Mauch H; Wagner S; Arndt G; Lode H
    Eur Respir J; 2003 Jun; 21(6):939-43. PubMed ID: 12797485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis.
    Huang CT; Lee LN; Ho CC; Shu CC; Ruan SY; Tsai YJ; Wang JY; Yu CJ
    J Infect; 2014 May; 68(5):440-7. PubMed ID: 24393650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum procalcitonin distinguishes CAP due to bacteria, Mycobacterium tuberculosis and PJP.
    Nyamande K; Lalloo UG
    Int J Tuberc Lung Dis; 2006 May; 10(5):510-5. PubMed ID: 16704032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin as a biomarker in respiratory tract infection.
    Gilbert DN
    Clin Infect Dis; 2011 May; 52 Suppl 4():S346-50. PubMed ID: 21460294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in lower respiratory tract infections.
    Blasi F; Stolz D; Piffer F
    Pulm Pharmacol Ther; 2010 Dec; 23(6):501-7. PubMed ID: 20434579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia.
    Kang YA; Kwon SY; Yoon HI; Lee JH; Lee CT
    Korean J Intern Med; 2009 Dec; 24(4):337-42. PubMed ID: 19949732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood.
    Don M; Valent F; Korppi M; Falleti E; De Candia A; Fasoli L; Tenore A; Canciani M
    Scand J Infect Dis; 2007; 39(2):129-37. PubMed ID: 17366029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of serum procalcitonin in treatment of community acquired pneumonia in outpatient].
    Long W; Deng XQ; Tang JG; Xie J; Zhang YC; Zhang Y; Gao YY; Lu G
    Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):216-9. PubMed ID: 19576090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The status of serum procalcitonin in pulmonary tuberculosis and nontuberculosis pulmonary disease.
    Naderi M; Hashemi M; Kouhpayeh H; Ahmadi R
    J Pak Med Assoc; 2009 Sep; 59(9):647-8. PubMed ID: 19750868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.